Monday, September 26, 2022 4:59:56 PM
Recent CMMB News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/16/2024 08:34:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:56:36 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/09/2024 10:16:11 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:09 AM
- Chemomab Therapeutics to Present at September 2024 Investor Conferences • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 08/23/2024 08:08:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 11:00:21 AM
- Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update • GlobeNewswire Inc. • 08/12/2024 11:00:00 AM
- Chemomab Therapeutics Announces Closing of $10 Million Private Placement • GlobeNewswire Inc. • 07/30/2024 01:00:00 PM
- Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 07/26/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2024 12:09:40 PM
- Chemomab Therapeutics Announces $10 Million Private Placement • GlobeNewswire Inc. • 07/25/2024 11:38:21 AM
- Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 07/25/2024 11:00:00 AM
- Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/18/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/12/2024 08:02:17 PM
- Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- Chemomab Therapeutics to Participate in Upcoming Scientific Conferences • GlobeNewswire Inc. • 05/17/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 11:00:40 AM
- Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 11:05:07 AM
- Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM